Cimivir-L Tablet
Marketer
Biocon
Salt Composition
Ledipasvir (90mg) + Sofosbuvir (400mg)
Overview Cimivir-L Tablet
HepCease Duo tablets contain a dual antiviral formulation, prescribed for managing chronic hepatitis C (HCV). This medication combats the HCV virus to achieve infection resolution. Adhere strictly to the prescribed dosage and regimen; it may be taken with or without food, but consistently at the same time each day. Exceeding the recommended dose is unsafe. Disclose any pre-existing conditions, particularly liver or kidney disease, to your physician. Alcohol consumption should be minimized or avoided entirely due to potential interactions. Completing the full course is crucial for optimal outcomes. Fatigue and cephalgia are commonly reported. Maintaining adequate hydration and a nutritious diet can help mitigate these side effects. Always inform your doctor about any other medications or supplements you are using before commencing treatment.
Primary Ingredients of Cimivir-L Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Cimivir-L Tablet
Managing persistent hepatitis C virus (HCV) infection
Major Benefits of Cimivir-L Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cimivir-L Tablets can be administered with or without food; however, consistent timing is recommended for optimal results.
Common Side effects of Cimivir-L Tablet:
- Tiredness
- Headache
How to use Cimivir-L Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Cimivir-L Tablets can be consumed with or without food, though consistent timing is recommended for optimal results.
How Cimivir-L Tablet works:
Ledipasvir and Sofosbuvir, the active components of Cimivir-L Tablet, act synergistically to reduce the hepatitis C viral load. This antiviral combination therapy gradually eliminates the virus from the bloodstream.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cimivir-L Tablet lacks established safety data. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The use of Cimivir-L Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and Cimivir-L Tablet use appear compatible. Available data from human studies indicate minimal infant risk associated with the medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Cimivir-L Tablets. Concomitant use of Cimivir-L Tablets and other hepatitis C medications can induce dizziness and blurred vision, potentially impacting driving safety.
KidneyCAUTION
Patients with severe kidney impairment should use Cimivir-L Tablets cautiously, potentially requiring dose modification. Consult a physician for guidance. Data regarding Cimivir-L Tablet use in such patients is limited. Dose alteration is not advised for individuals with mild or moderate kidney disease.
LiverSAFE IF PRESCRIBED
Cimivir-L tablets pose no safety concerns for patients with hepatic impairment; no dosage modifications are necessary.
What if you forget to take Cimivir-L Tablet :
Should you forget a Cimivir-L Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cimivir-L Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently